Product
Medroxyprogestrone
1 clinical trial
1 indication
Indication
PRKClinical trial
Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2023Status: Completed, Estimated PCD: 2023-06-21